HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Song H, Li D, Wang X, Fang E, Yang F, Hu A, Wang J, Guo Y, Liu Y, Li H, Chen Y, Huang K, Zheng L, Tong Q.
Song H, et al. Among authors: tong q.
J Hematol Oncol. 2020 Mar 26;13(1):24. doi: 10.1186/s13045-020-00857-7.
J Hematol Oncol. 2020.
PMID: 32216806
Free PMC article.
Retracted.